Preliminary scientific studies point out conolidine may inhibit particular ion channels, cutting down neuronal excitability and limiting suffering indicators. This system is particularly pertinent in neuropathic suffering, where abnormal signaling will cause persistent discomfort. Moreover, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to agony notion.... https://agnesb703aun9.wssblogs.com/profile